ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest diabetes news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks diabetes across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Harvard-led researchers silenced ALDH3B2 in human ductal cells, raising beta-like conversion from under 1 percent to about 8.5 percent. Transplanted into diabetic mice, the cells produced human insulin and lowered glucose to near-normal for six weeks. The work, published in Science Translational Medicine, suggests reprogramming existing pancreatic cells rather than replacing them.
Summaries by ByteBrief